Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis in a patient with a predisposition to autoimmune abnormalities

Modern Rheumatology

Volumn 13, Issue 2, 2003, Pages 173-176

  Iyoda, Masayuki ^a   Kuroki, Aki ^a   Kato, Kenichi ^a   Shibata, Takanori ^a   Kitazawa, Kozo ^a   Sugisaki, Tetsuzo ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Antineutrophil cytoplasmic antibody (ANCA); Autoimmunity; Crescentic glomerulonephritis (GN); Primary biliary cirrhosis (PBC); Propylthiouracil (PTU)

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; HLA DR ANTIGEN; HLA DR4 ANTIGEN; LIOTHYRONINE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; PROPYLTHIOURACIL; THIAMAZOLE; THYROID ANTIBODY; URSODEOXYCHOLIC ACID;

AGED; ANAMNESIS; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CASE REPORT; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; GENETIC PREDISPOSITION; GRAVES DISEASE; HAPLOTYPE; HUMAN; IMMUNOPATHOGENESIS; KIDNEY BIOPSY; KIDNEY FUNCTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; VASCULITIS;

EID: 0041671114     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.3109/s10165-002-0218-1     Document Type: Article

References (16)

1. Gunton JE, Stiel J, Caterson RJ, Mcelduff A. Antithyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab 1999;84:13-6.
2. Sera N, Ashizawa K, Ando T, Abe Y, Ide A, Usa T, et al. Treatment with propylthiouracil is associated with the appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid 2000;10:595-9.
3. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II associated differences in the production of tumor necrosis factor a: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990;87:1233-7.
4. Fujii A, Tomizaka K, Arimura Y, Nagasawa T, Ohashi Y, Hiyama T, et al. Epitope analysis of myeloperoxidase (MPO)-specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis. Clin Nephrol 2000;53:242-52.
5. Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of class I and class I major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990;11:12-5.
6. Lacaille F, Paradis K. The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells. Hepatology 1993;18:165-72.
7. Yoshikawa M, Tsujii T, Matsumura K, Yamao J, Matsumura Y, Kubo R, et al. Immunoregulatory effects of ursodeoxycholic acid on immune responses. Hepatology 1992;16:358-64.
8. Yoshikawa M, Matsumura K, Matsumura Y, Yamao J, Kuriyama S, Ishizaka S, et al. Effects of ursodeoxycholic acid on antigen presentation. Intern Hepatol Commun 1993;1:243-9.
9. Lee E, Hirouchi M, Hosokawa M, Sayo H, Kohno M, Kariya K. Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure. Biochem Pharmacol 1988;37:2151-3.
10. Morita S, Ueda Y, Eguchi K. Anti-thyroid drug-induced ANCA-associated vasculitis: a case report and review of the literature. Endocr J 2000;47:467-70.
11. Kallenberg CGM, Brouwer E, Weening JJ, Tervaert JWC. Anti-neutrophil cytoplasmic antibodies: current diagnostic and patho-physiological potential. Kidney Int 1994;46:1-15.
12. Van de Wiel A, Dolman KM, Van der Meer-Gerritsen CH, Hack CE, Von dem Borne AEGKR, Goldschmeding R. Interference of Wegener's granulomatosis autoantibodies with neutrophil proteinase 3 activity. Clin Exp Immunol 1992;90:409-14.
13. 1-antitrypsin complexation to disease activity in Wegener's granulomatosis. Clin Exp Immunol 1993;93:405-10.
14. Charles LA, Caldas MLR, Falk RJ, Terrel RS, Jennette JC. Antibodies against granule proteins activate neutrophils in vitro. J Leuk Biol 1991;50:539-46.
15. Porges AJ, Redecha PB, Csernok E, Gross WL, Kimberly RP. Monoclonal ANCA (anti-MPO and anti-Pr3) engage and activate neutrophils via Fcg receptor IIA. Clin Exp Immunol 1993;93Suppl 1:S18.
16. Spencer SJW, Burns A, Gaskin G, Pusey CD, Rees AJ. HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens. Kidney Int 1992;41:1059-63.